Selected research
Market Analysis & Forecast
Global Pulmonary Dilation Balloon Market Analysis and Forecast 2026-2032
Market perspective
The global Pulmonary Dilation Balloon market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Pulmonary Dilation Balloon is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Pulmonary Dilation Balloon is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Pulmonary Dilation Balloon is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Pulmonary Dilation Balloon is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Pulmonary Dilation Balloon include Grand Pharmaceutical, Yinyi Biotech, Acotec Scientific, MicroPort Scientific, Sino Medical, Lepu Medical, Shanghai Kinetic Medical Co.,Ltd., Merit Medical and Envaste Medical Instruments, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Pulmonary Dilation Balloon, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Pulmonary Dilation Balloon, also provides the revenue of main regions and countries. Of the upcoming market potential for Pulmonary Dilation Balloon, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pulmonary Dilation Balloon revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pulmonary Dilation Balloon market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pulmonary Dilation Balloon revenue, projected growth trends, production technology, application and end-user industry.
Pulmonary Dilation Balloon Segment by Company
Grand Pharmaceutical
Yinyi Biotech
Acotec Scientific
MicroPort Scientific
Sino Medical
Lepu Medical
Shanghai Kinetic Medical Co.,Ltd.
Merit Medical
Envaste Medical Instruments
Boston Scientific
Pulmonary Dilation Balloon Segment by Type
Elation™
CRE™
Pulmonary Dilation Balloon Segment by Application
Hospitals
Ambulatory Surgical Centers
Clinics
Pulmonary Dilation Balloon Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pulmonary Dilation Balloon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pulmonary Dilation Balloon and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pulmonary Dilation Balloon.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Pulmonary Dilation Balloon in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Pulmonary Dilation Balloon company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pulmonary Dilation Balloon revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Elation™
- CRE™
Applications
- Hospitals
- Ambulatory Surgical Centers
- Clinics
Companies covered
- Grand Pharmaceutical
- Yinyi Biotech
- Acotec Scientific
- MicroPort Scientific
- Sino Medical
- Lepu Medical
- Shanghai Kinetic Medical Co.,Ltd.
- Merit Medical
- Envaste Medical Instruments
- Boston Scientific
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Pulmonary Dilation Balloon Market by Type
- 1.2.1 Global Pulmonary Dilation Balloon Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Elation™
- 1.2.3 CRE™
- 1.3 Pulmonary Dilation Balloon Market by Application
- 1.3.1 Global Pulmonary Dilation Balloon Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospitals
- 1.3.3 Ambulatory Surgical Centers
- 1.3.4 Clinics
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pulmonary Dilation Balloon Market Dynamics
- 2.1 Pulmonary Dilation Balloon Industry Trends
- 2.2 Pulmonary Dilation Balloon Industry Drivers
- 2.3 Pulmonary Dilation Balloon Industry Opportunities and Challenges
- 2.4 Pulmonary Dilation Balloon Industry Restraints
3 Global Growth Perspective
- 3.1 Global Pulmonary Dilation Balloon Market Perspective (2021-2032)
- 3.2 Global Pulmonary Dilation Balloon Growth Trends by Region
- 3.2.1 Global Pulmonary Dilation Balloon Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Pulmonary Dilation Balloon Market Size by Region (2021-2026)
- 3.2.3 Global Pulmonary Dilation Balloon Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Pulmonary Dilation Balloon Revenue by Players
- 4.1.1 Global Pulmonary Dilation Balloon Revenue by Players (2021-2026)
- 4.1.2 Global Pulmonary Dilation Balloon Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Pulmonary Dilation Balloon Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Pulmonary Dilation Balloon Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Pulmonary Dilation Balloon Key Players Headquarters & Area Served
- 4.4 Global Pulmonary Dilation Balloon Players, Product Type & Application
- 4.5 Global Pulmonary Dilation Balloon Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Pulmonary Dilation Balloon Market CR5 and HHI
- 4.6.3 2025 Pulmonary Dilation Balloon Tier 1, Tier 2, and Tier 3
5 Pulmonary Dilation Balloon Market Size by Type
- 5.1 Global Pulmonary Dilation Balloon Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Pulmonary Dilation Balloon Revenue by Type (2021-2032)
- 5.3 Global Pulmonary Dilation Balloon Revenue Market Share by Type (2021-2032)
6 Pulmonary Dilation Balloon Market Size by Application
- 6.1 Global Pulmonary Dilation Balloon Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Pulmonary Dilation Balloon Revenue by Application (2021-2032)
- 6.3 Global Pulmonary Dilation Balloon Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Grand Pharmaceutical
- 7.1.1 Grand Pharmaceutical Company Information
- 7.1.2 Grand Pharmaceutical Business Overview
- 7.1.3 Grand Pharmaceutical Pulmonary Dilation Balloon Revenue and Gross Margin (2021-2026)
- 7.1.4 Grand Pharmaceutical Pulmonary Dilation Balloon Product Portfolio
- 7.1.5 Grand Pharmaceutical Recent Developments
- 7.2 Yinyi Biotech
- 7.2.1 Yinyi Biotech Company Information
- 7.2.2 Yinyi Biotech Business Overview
- 7.2.3 Yinyi Biotech Pulmonary Dilation Balloon Revenue and Gross Margin (2021-2026)
- 7.2.4 Yinyi Biotech Pulmonary Dilation Balloon Product Portfolio
- 7.2.5 Yinyi Biotech Recent Developments
- 7.3 Acotec Scientific
- 7.3.1 Acotec Scientific Company Information
- 7.3.2 Acotec Scientific Business Overview
- 7.3.3 Acotec Scientific Pulmonary Dilation Balloon Revenue and Gross Margin (2021-2026)
- 7.3.4 Acotec Scientific Pulmonary Dilation Balloon Product Portfolio
- 7.3.5 Acotec Scientific Recent Developments
- 7.4 MicroPort Scientific
- 7.4.1 MicroPort Scientific Company Information
- 7.4.2 MicroPort Scientific Business Overview
- 7.4.3 MicroPort Scientific Pulmonary Dilation Balloon Revenue and Gross Margin (2021-2026)
- 7.4.4 MicroPort Scientific Pulmonary Dilation Balloon Product Portfolio
- 7.4.5 MicroPort Scientific Recent Developments
- 7.5 Sino Medical
- 7.5.1 Sino Medical Company Information
- 7.5.2 Sino Medical Business Overview
- 7.5.3 Sino Medical Pulmonary Dilation Balloon Revenue and Gross Margin (2021-2026)
- 7.5.4 Sino Medical Pulmonary Dilation Balloon Product Portfolio
- 7.5.5 Sino Medical Recent Developments
- 7.6 Lepu Medical
- 7.6.1 Lepu Medical Company Information
- 7.6.2 Lepu Medical Business Overview
- 7.6.3 Lepu Medical Pulmonary Dilation Balloon Revenue and Gross Margin (2021-2026)
- 7.6.4 Lepu Medical Pulmonary Dilation Balloon Product Portfolio
- 7.6.5 Lepu Medical Recent Developments
- 7.7 Shanghai Kinetic Medical Co.,Ltd.
- 7.7.1 Shanghai Kinetic Medical Co.,Ltd. Company Information
- 7.7.2 Shanghai Kinetic Medical Co.,Ltd. Business Overview
- 7.7.3 Shanghai Kinetic Medical Co.,Ltd. Pulmonary Dilation Balloon Revenue and Gross Margin (2021-2026)
- 7.7.4 Shanghai Kinetic Medical Co.,Ltd. Pulmonary Dilation Balloon Product Portfolio
- 7.7.5 Shanghai Kinetic Medical Co.,Ltd. Recent Developments
- 7.8 Merit Medical
- 7.8.1 Merit Medical Company Information
- 7.8.2 Merit Medical Business Overview
- 7.8.3 Merit Medical Pulmonary Dilation Balloon Revenue and Gross Margin (2021-2026)
- 7.8.4 Merit Medical Pulmonary Dilation Balloon Product Portfolio
- 7.8.5 Merit Medical Recent Developments
- 7.9 Envaste Medical Instruments
- 7.9.1 Envaste Medical Instruments Company Information
- 7.9.2 Envaste Medical Instruments Business Overview
- 7.9.3 Envaste Medical Instruments Pulmonary Dilation Balloon Revenue and Gross Margin (2021-2026)
- 7.9.4 Envaste Medical Instruments Pulmonary Dilation Balloon Product Portfolio
- 7.9.5 Envaste Medical Instruments Recent Developments
- 7.10 Boston Scientific
- 7.10.1 Boston Scientific Company Information
- 7.10.2 Boston Scientific Business Overview
- 7.10.3 Boston Scientific Pulmonary Dilation Balloon Revenue and Gross Margin (2021-2026)
- 7.10.4 Boston Scientific Pulmonary Dilation Balloon Product Portfolio
- 7.10.5 Boston Scientific Recent Developments
8 North America
- 8.1 North America Pulmonary Dilation Balloon Revenue (2021-2032)
- 8.2 North America Pulmonary Dilation Balloon Revenue by Type (2021-2032)
- 8.2.1 North America Pulmonary Dilation Balloon Revenue by Type (2021-2026)
- 8.2.2 North America Pulmonary Dilation Balloon Revenue by Type (2027-2032)
- 8.3 North America Pulmonary Dilation Balloon Revenue Share by Type (2021-2032)
- 8.4 North America Pulmonary Dilation Balloon Revenue by Application (2021-2032)
- 8.4.1 North America Pulmonary Dilation Balloon Revenue by Application (2021-2026)
- 8.4.2 North America Pulmonary Dilation Balloon Revenue by Application (2027-2032)
- 8.5 North America Pulmonary Dilation Balloon Revenue Share by Application (2021-2032)
- 8.6 North America Pulmonary Dilation Balloon Revenue by Country
- 8.6.1 North America Pulmonary Dilation Balloon Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Pulmonary Dilation Balloon Revenue by Country (2021-2026)
- 8.6.3 North America Pulmonary Dilation Balloon Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
9 Europe
- 9.1 Europe Pulmonary Dilation Balloon Revenue (2021-2032)
- 9.2 Europe Pulmonary Dilation Balloon Revenue by Type (2021-2032)
- 9.2.1 Europe Pulmonary Dilation Balloon Revenue by Type (2021-2026)
- 9.2.2 Europe Pulmonary Dilation Balloon Revenue by Type (2027-2032)
- 9.3 Europe Pulmonary Dilation Balloon Revenue Share by Type (2021-2032)
- 9.4 Europe Pulmonary Dilation Balloon Revenue by Application (2021-2032)
- 9.4.1 Europe Pulmonary Dilation Balloon Revenue by Application (2021-2026)
- 9.4.2 Europe Pulmonary Dilation Balloon Revenue by Application (2027-2032)
- 9.5 Europe Pulmonary Dilation Balloon Revenue Share by Application (2021-2032)
- 9.6 Europe Pulmonary Dilation Balloon Revenue by Country
- 9.6.1 Europe Pulmonary Dilation Balloon Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Pulmonary Dilation Balloon Revenue by Country (2021-2026)
- 9.6.3 Europe Pulmonary Dilation Balloon Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Netherlands
- 9.6.9 Nordic Countries
10 China
- 10.1 China Pulmonary Dilation Balloon Revenue (2021-2032)
- 10.2 China Pulmonary Dilation Balloon Revenue by Type (2021-2032)
- 10.2.1 China Pulmonary Dilation Balloon Revenue by Type (2021-2026)
- 10.2.2 China Pulmonary Dilation Balloon Revenue by Type (2027-2032)
- 10.3 China Pulmonary Dilation Balloon Revenue Share by Type (2021-2032)
- 10.4 China Pulmonary Dilation Balloon Revenue by Application (2021-2032)
- 10.4.1 China Pulmonary Dilation Balloon Revenue by Application (2021-2026)
- 10.4.2 China Pulmonary Dilation Balloon Revenue by Application (2027-2032)
- 10.5 China Pulmonary Dilation Balloon Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Pulmonary Dilation Balloon Revenue (2021-2032)
- 11.2 Asia Pulmonary Dilation Balloon Revenue by Type (2021-2032)
- 11.2.1 Asia Pulmonary Dilation Balloon Revenue by Type (2021-2026)
- 11.2.2 Asia Pulmonary Dilation Balloon Revenue by Type (2027-2032)
- 11.3 Asia Pulmonary Dilation Balloon Revenue Share by Type (2021-2032)
- 11.4 Asia Pulmonary Dilation Balloon Revenue by Application (2021-2032)
- 11.4.1 Asia Pulmonary Dilation Balloon Revenue by Application (2021-2026)
- 11.4.2 Asia Pulmonary Dilation Balloon Revenue by Application (2027-2032)
- 11.5 Asia Pulmonary Dilation Balloon Revenue Share by Application (2021-2032)
- 11.6 Asia Pulmonary Dilation Balloon Revenue by Country
- 11.6.1 Asia Pulmonary Dilation Balloon Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Pulmonary Dilation Balloon Revenue by Country (2021-2026)
- 11.6.3 Asia Pulmonary Dilation Balloon Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Pulmonary Dilation Balloon Revenue (2021-2032)
- 12.2 SAMEA Pulmonary Dilation Balloon Revenue by Type (2021-2032)
- 12.2.1 SAMEA Pulmonary Dilation Balloon Revenue by Type (2021-2026)
- 12.2.2 SAMEA Pulmonary Dilation Balloon Revenue by Type (2027-2032)
- 12.3 SAMEA Pulmonary Dilation Balloon Revenue Share by Type (2021-2032)
- 12.4 SAMEA Pulmonary Dilation Balloon Revenue by Application (2021-2032)
- 12.4.1 SAMEA Pulmonary Dilation Balloon Revenue by Application (2021-2026)
- 12.4.2 SAMEA Pulmonary Dilation Balloon Revenue by Application (2027-2032)
- 12.5 SAMEA Pulmonary Dilation Balloon Revenue Share by Application (2021-2032)
- 12.6 SAMEA Pulmonary Dilation Balloon Revenue by Country
- 12.6.1 SAMEA Pulmonary Dilation Balloon Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Pulmonary Dilation Balloon Revenue by Country (2021-2026)
- 12.6.3 SAMEA Pulmonary Dilation Balloon Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst